Consensus Methods

A discussion on how extractors need to monitor the chemical processes they perform.

How will the need for increased testing impact extractors?

This article intends to clarify the main goals of GACP and GMP guidelines, identify differences between the two, and also explore why it is important, when operating within the medicinal cannabis sector, that these two guidelines are complied with and their standards achieved.

What does FDA oversight mean for cannabis businesses and the industry as a whole?

Highlights of the challenges facing the cannabis extracts industry and discussion about the need for standardized methods and the role of laboratory accreditation.

Here we examine the history of cannabis in the US, the role the USP played in that field, and the new role the USP is taking with cannabis for medical use.

What to consider when creating or using certified reference materials.

George Anastassov, the CEO of AXIM Biotech, recently spoke to us about the current good manufacturing methods (cGMPs) his company has developed, their significance to the market, and plans for the future.

An interview with Cynthia Ludwig

An interview with Susan Audino

An interview with Jeffrey C. Raber